The pathophysiology of hypoactive sexual desire disorder in women

被引:58
作者
Clayton, Anita H. [1 ]
机构
[1] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22903 USA
关键词
Female sexual dysfunction; Hypoactive Sexual Desire Disorder; HSDD; Pathophysiology; Risk factors; UNITED-STATES; DYSFUNCTION; PREVALENCE; IMPACT; BEHAVIOR; DEFINITION; ANDROGENS; ATTITUDES; DISTRESS; MODELS;
D O I
10.1016/j.ijgo.2010.02.014
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Hypoactive sexual desire disorder (HSDD) is defined as a deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty. The dysfunction cannot be better accounted for by another psychiatric disorder (except another sexual dysfunction) and must not be due exclusively to the physiological effects of a substance or a general medical condition. HSDD occurs in approximately I in 10 adult women in the USA and its prevalence appears lobe similar in Europe. A number of potential causative and contributory factors to low sexual desire have been identified, reflecting the interplay among hormonal, neurobiological, and psychosocial factors. One theory is that sexual desire is controlled in the brain by a balance between inhibitory and excitatory factors. In general, dopamine, estrogen, progesterone, and testosterone play an excitatory role in sexual desire, whereas serotonin, prolactin, and opioids play an inhibitory role. It is hypothesized that decreased sexual desire may be due to a reduced level of excitatory activity, an increased level of inhibitory activity, or both. A greater understanding of the complex pathophysiology of HSDD would improve the identification and management of women for whom low sexual desire is a concern. (C) 2010 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 46 条
[1]   Sexual dysfunction after premenopausal Stage I and II breast cancer: Do androgens play a role? [J].
Alder, Judith ;
Zanetti, Rosanna ;
Wight, Edward ;
Urech, Corinne ;
Fink, Nadine ;
Bitzer, Johannes .
JOURNAL OF SEXUAL MEDICINE, 2008, 5 (08) :1898-1906
[2]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[3]   Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment [J].
Bachmann, G ;
Bancroft, J ;
Braunstein, G ;
Burger, H ;
Davis, S ;
Dennerstein, L ;
Goldstein, I ;
Guay, A ;
Leiblum, S ;
Lobo, R ;
Notelovitz, M ;
Rosen, R ;
Sarrel, P ;
Sherwin, B ;
Simon, J ;
Simpson, E ;
Shifren, J ;
Spark, R ;
Traish, A .
FERTILITY AND STERILITY, 2002, 77 (04) :660-665
[4]   Female sexuality and sexual dysfunction: Are we stuck on the learning curve? [J].
Bachmann, Gloria .
JOURNAL OF SEXUAL MEDICINE, 2006, 3 (04) :639-645
[5]  
Bancroft J, 2003, ARCH SEX BEHAV, V32, P193, DOI 10.1023/A:1023420431760
[6]   Recent advances in women's sexual function and dysfunction [J].
Basson, R .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (06) :714-725
[7]   Female sexual response: The role of drugs in the management of sexual dysfunction [J].
Basson, R .
OBSTETRICS AND GYNECOLOGY, 2001, 98 (02) :350-353
[8]   Sexual Dysfunction 1 - Sexual sequelae of general medical disorders [J].
Basson, Rosemary ;
Schultz, Willibrord Weijmar .
LANCET, 2007, 369 (9559) :409-424
[9]   DIRECT EFFECT OF 17-BETA-ESTRADIOL ON STRIATUM - SEX-DIFFERENCES IN DOPAMINE RELEASE [J].
BECKER, JB .
SYNAPSE, 1990, 5 (02) :157-164
[10]   Sexual disorders in subjects treated for mood and anxiety diseases [J].
Bossini, Letizia ;
Fagiolini, Andrea ;
Valdagno, Marta ;
Polizzotto, Nicola Riccardo ;
Castrogiovanni, Paolo .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (03) :310-312